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1. INTRODUCTION physiological pH and eluting conditions was not 
detected. 
The reaction of polysaccharide supports with 
cyanogen bromide [ 1,2] continues to be the most 
widely used method for binding amino ligands. 
However, the cyanogen bromide activation meth- 
od suffers from several disadvantages, uch as, in- 
stability of the isourea bond formed by the ligands 
and the polysaccharide supports, resulting in con- 
tinous leakage of the ligands from the supports 
into the solution, high toxicity of cyanogen bro- 
mide and high pH needed for the activation pro- 
cedure. Several new immunoabsorbents and ac- 
tivation procedures have been developed in the 
search for better supports and coupling methods 
[2-61. In the present publication the synthesis and 
the application in affinity chromatography of new 
effective immunoabsorbents based on agarose 
polyacrolein microspheres beads (PAMB) is de- 
scribed [7]. Polyacrolein microspheres (PA, 4% 
wt/vol) were encapsulated with agarose (4% wt/ 
vol) to form beads ranging from 50 pm to 150 pm 
diameter. Magnetic APAMB were formed by car- 
rying out the encapsulation procedure in the pre- 
sence of magnetic particles (Ferrofluid). Various 
ligands containing primary amino groups, such as 
proteins, antibodies, lectins, hormones and drugs 
were bound covalently in a single step under phys- 
iological pH to the beads through their aldehyde 
groups. The potential use of some of the conju- 
gates: beads-proteins (immunobeads) in affinity 
chromatography was illustrated successfully. 
Leaching of proteins bound to the beads under 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Goat anti-mouse immunoglobulin (gxmIg) and 
monoclonal anti-mouse Thyl,2 were obtained 
from Z. Eshhar, Rehovot, Israel. All other chemi- 
cals were from standard commercial suppliers. 
2.2. Antisera 
Rabbit and goat antisera used in this work were 
obtained by immunizing the animals with an 
emulsion containing the appropriate antigen in 
Freunds complete adjuvant (1 mg/ml of antigen, 
final concentration). Each animal received 2 ml in- 
jected intradermally into at least 10 different sites. 
The animals were boosted 10 days after the first 
dose in the same manner. 
2.3. Determination of proteins 
Quantities of proteins bound to the beads were 
determined by measuring the unbound proteins 
with the Folin-Ciocalteau reagent using Lowry’s 
method [8]. Quantities of antibodies bound and 
eluted from the immunobeads were determined by 
the quantitative precipitation reaction [9]. 
2.4. Synthesis of PA microspheres 
PA microspheres were synthesized by poly- 
merizing acrolein with a cobalt radiation, as de- 
scribed in a previous publication [lo]. 
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2.5. Synthesis of the APAMB [7] 2.0. Isolation of antibodies 
A solution containing 0.96 g agarose A in 16 ml 
distilled water was heated to 95 “C until the gel was 
melted into a clear solution. The temperature was 
then decreased to 70°C and 8 ml of PA micro- 
spheres olution (12% wt/vol) heated to 70°C were 
added. The solution was stirred for another 30 
minutes and was then poured into 100 ml of stirred 
(3000 rev./min) peanut oil at 70°C. Ten minutes 
later the solution was cooled with ice. The 
APAMB produced were purified from the oil with 
ether which was then removed by evaporation. 
Magnetic APAMB were formed by carrying out 
the same procedure in the presence of ferrofluid 
(5% wt/vol). 
2.6. Binding of the spacer polylysine-glutaralde- 
hyde to the APAMB 
The immune serum was passed in a rate of 1 ml/ 
min through a column containing the appropriate 
immunoabsorbent (5 to 10 ml serum for each 1 ml 
of the immunobeads). The immunobeads were 
then washed several times with PBS. Absorbed 
antibodies were then eluted with 0.2 M glycine- 
HCl buffer solution at pH 2.4, neutralized with 
NaOH, dialysed against PBS and then analysed by 
polyacrylamide gel electrophoresis [111. The im- 
munobeads, after the treatment with glycine-HCl 
buffer, were washed several times with PBS and 
stored at 4°C in presence of sodium azide (O.OSYX) 
until reused. The isolation of antibodies with the 
immunomagnetic beads was carried out batchwise. 
The removal of unbound antibodies and the wash- 
ing steps was achieved by successive decantation 
with a magnetic field. 
Twenty ml of the APAMB in 35 ml of distilled 
water were shaken for 24 h with 40 mg of poly- 
lysine. The polylysine conjugated beads produced 
were washed free of unbound polylysine by re- 
peated decantation. The beads solution (20 ml in 
35 ml H20) was then shaken for 12 h with 2 ml 
glutaraldehyde (50%) and the resultant poly- 
lysine-glutaraldehyde conjugated beads were fil- 
tered and then washed with large amounts of dis- 
tilled water. The binding of polylysine-glutaralde- 
hyde to the magnetic APAMB was carried out in a 
similar procedure. The derivatized magnetic beads 
were washed free of unbound spacer by repeated 
decantation in the presence of a magnetic field. 
3. RESULTS AND DISCUSSION 
2.7. Preparation of the immunoabsorbents 
Fig.la represents a light microscopy picture of 
the APAMB. Cross-section photomicrographs of 
the PA microspheres and the magnetic particles 
encapsulated in the agarose are shown in fig. 1 b 
and c, respectively. Amino ligands, e.g., proteins, 
diffuse through the porous agarose and bind 
covalently in a single step under physiological pH 
to the PA microspheres to form the polyvalent 
Schiff base bonds. A further reduction of a Schiff 
base bond to a stable single C-N bond [6,12] may 
be required when the ligand bound to the beads is 
provided only with a single amino group. 
Twenty ml of the APAMB with or without a 
bound spacer were shaken for 24 h at 4°C with 400 
mg of an appropriate antigen in 200 ml PBS. Un- 
bound antigen was then removed by repeated de- 
cantation with large amounts of phosphate buffer 
saline (PBS). The remaining aldehyde groups were 
then blocked by shaking the beads for 12 h with 
1 ml ethanol amine solution, brought to pH 7.2 
with HCl. The immunobeads were then washed 
successively with PBS, eluting medium (0.2 M 
glycine-HCl buffer at pH 2.4) and again with 
PBS. The preparation of the magnetic immunoab- 
sorbents was similar. The removal of the unbound 
antigen and ethanol amine was achieved by re- 
peated decantation with PBS in the presence of a 
magnetic field. 
The binding capacity of the APAMB towards 
various amino ligands, e.g., proteins (BSA, DNP- 
BSA, and RIgG), antibodies (gxmIg and anti- 
mouse Thy1,2), lectins (Con A and soybean ag- 
glutinin), hormones (bovine insulin) and drugs 
(Desferoxamine, an iron chelating agent) are illus- 
trated in table 1. Steric requirements may explain 
the significant increase (3-6-fold) in the binding 
capacity of the APAMB bound to the spacer arm 
polylysine-gluteraldehyde. The beads preserved 
their physical and mechanical properties after the 
coupling of the ligands. Leakage of bound proteins 
from the beads to the supernatant was not detected 
by using the method of Lowry et al. [8] for protein 
determination. Furthermore, radioactivity in the 
supernatant of a solution containing beads bound 
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Table 1 
Binding capacity of the APAMB to various amino ligands 
Ligands Spacer Binding capacity (mg) 
APAMB Magnetic APAMB 
BSA 
BSA 
DNP-BSA 
DNP-BSA 
RIgG 
Soybean agglutinin 
RIgG 
Con A 
Con A 
Bovine insulin 
Bovine insulin 
gxm Ig
gxmIg 
Anti-mouse Thyl,2 
Desferoxamine 
- 
Polylysine-glutaraldehyde 
_ 
Polylysine-glutaraldehyde 
- 
Polylysine-glutaraldehyde 
Polylysine-glutaraldehyde 
_ 
Polylysine-glutaraldehyde 
Polylysine-glutaraldehyde 
- 
Polylysine-glutaraldehyde 
Polylysine-glutaraldehyde 
Polylysine-glutaraldehyde 
2.2 2.2 
14.8 14.0 
1.8 
9.0 _ 
1.0 1.0 
5.9 
10.0 8.0 
2.4 - 
11.5 _ 
1.2 _ 
22.0 
2.4 - 
12.4 - 
9.8 
40.0 
1 ml of the APAMB was shaken with excess quantities of the various ligands in 5 ml 
PBS for 12 h at room temperature 
to radioactive BSA 1311 was not detected during 
the radioactive iodine life time. 
The binding capacity of some of the immu- 
nobeads to the appropriate antibodies and the re- 
sultant eluting data are given in table 2. In all cases 
antibodies were not detected after the adsorption 
step, as was determined by the ring test with the 
antisera. Antibodies eluted from the column were 
submitted to analysis by polyacrylamide gel elec- 
trophoresis and were found to contain only IgG. 
Normal rabbit serum was passed through a col- 
umn containing the immunobeads. The beads 
were then treated as described for the isolation of 
antibodies. Under these conditions proteins were 
not eluted from the beads, indicating that non-spe- 
cific absorption of proteins onto the beads did not 
occur. The immunobeads have also used repeatly 
during a period of 6 months without any signifi- 
cant loss of their antibody binding capacity, as 
shown in table 3. 
Table 2 
Isolation of antibodies with the agarose polyacrolein immunoabsorbents (1 ml APAMB) 
Beads Spacer Antigen Antigen Antiserum Antibody Antibody 
bound used bound eluted 
(mg) (mg) (mg) 
APAMB - BSA 2.2 Rabbit 2.4 2.2 
APAMB Polylysine-glutaraldehyde BSA 14.8 Rabbit 16.5 17.0 
APAMB Polylysine-glutaraldehyde DNP-BSA 9.2 Rabbit 8.5 8.4 
APAMB Polylysine-glutaraldehyde RIgG 10.0 Goat 12.0 12.0 
Magnetic 
APAMB 
3.0 
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Fig.1. (a) A light microscopy phctomicrograph of the 
APAMB (X 100). (b) A Transmission Electron Micro- 
scopy (TEM) picture describing a cross section of the 
APAMB (X 3300). (c) A TEM picture describing a cross 
section of the magnetic APAMB (X 55 000). 
In conclusion, in a previous publication [lo], the 
use of PA microspheres for cell labeling and cell 
separation was demonstrated. In the present paper 
the PA microspheres were encapsulated in agarose 
and the resultant APAMB were used successfully 
as new immunoabsorbents in affinity chromatog- 
Table 3 
Quantity of rabbit anti BSA eluted from the APAMB 
bound to polylysine-glutaraldehyde during 3 succesive 
isolations in 6 months 
Time 
(months) 
Rabbit anti-BSA 
eluted (mg) 
1 16.5 
3 16.0 
6 17.0 
1 ml beads bound to 14.8 mg BSA 
raphy. Currently, research related to the potential 
use of the APAMB for other biological applica- 
tions, e.g., diagnostic purposes, cell separation and 
hemoperfusion is on going in our group and will 
be published in the future. 
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